Annual EBIT
-$66.19 M
-$7.00 M-11.83%
December 31, 2023
Summary
- As of February 8, 2025, LXEO annual earnings before interest & taxes is -$66.19 million, with the most recent change of -$7.00 million (-11.83%) on December 31, 2023.
- During the last 3 years, LXEO annual EBIT has fallen by -$61.60 million (-1342.72%).
- LXEO annual EBIT is now -1342.72% below its all-time high of -$4.59 million, reached on December 1, 2020.
Performance
LXEO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$29.45 M
-$8.25 M-38.91%
September 30, 2024
Summary
- As of February 8, 2025, LXEO quarterly earnings before interest & taxes is -$29.45 million, with the most recent change of -$8.25 million (-38.91%) on September 30, 2024.
- Over the past year, LXEO quarterly EBIT has dropped by -$9.40 million (-46.86%).
- LXEO quarterly EBIT is now -120.00% below its all-time high of -$13.39 million, reached on June 30, 2023.
Performance
LXEO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$86.44 M
-$9.40 M-12.20%
September 30, 2024
Summary
- As of February 8, 2025, LXEO TTM earnings before interest & taxes is -$86.44 million, with the most recent change of -$9.40 million (-12.20%) on September 30, 2024.
- Over the past year, LXEO TTM EBIT has dropped by -$19.86 million (-29.84%).
- LXEO TTM EBIT is now -471.16% below its all-time high of -$15.13 million, reached on June 30, 2022.
Performance
LXEO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LXEO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -11.8% | -46.9% | -29.8% |
| 3 y3 years | -1342.7% | -46.9% | -29.8% |
| 5 y5 years | -1342.7% | -46.9% | -29.8% |
LXEO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.8% | at low | -120.0% | at low | -471.2% | at low |
| 5 y | 5-year | -1342.7% | at low | -120.0% | at low | -471.2% | at low |
| alltime | all time | -1342.7% | at low | -120.0% | at low | -471.2% | at low |
Lexeo Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$29.45 M(+38.9%) | -$86.44 M(+12.2%) |
| Jun 2024 | - | -$21.20 M(-2.0%) | -$77.04 M(+11.3%) |
| Mar 2024 | - | -$21.64 M(+53.1%) | -$69.23 M(+4.6%) |
| Dec 2023 | -$66.19 M | -$14.14 M(-29.5%) | -$66.19 M(-0.6%) |
| Sep 2023 | - | -$20.06 M(+49.8%) | -$66.57 M(+4.8%) |
| Jun 2023 | - | -$13.39 M(-28.0%) | -$63.54 M(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$18.61 M(+28.1%) | -$65.29 M(+39.9%) |
| Dec 2022 | -$59.19 M(+16.9%) | -$14.52 M(-14.7%) | -$46.68 M(+45.2%) |
| Sep 2022 | - | -$17.03 M(+12.5%) | -$32.16 M(+112.5%) |
| Jun 2022 | - | -$15.13 M | -$15.13 M |
| Dec 2021 | -$50.62 M(+1003.4%) | - | - |
| Dec 2020 | -$4.59 M | - | - |
FAQ
- What is Lexeo Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Lexeo Therapeutics?
- What is Lexeo Therapeutics annual EBIT year-on-year change?
- What is Lexeo Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Lexeo Therapeutics?
- What is Lexeo Therapeutics quarterly EBIT year-on-year change?
- What is Lexeo Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Lexeo Therapeutics?
- What is Lexeo Therapeutics TTM EBIT year-on-year change?
What is Lexeo Therapeutics annual earnings before interest & taxes?
The current annual EBIT of LXEO is -$66.19 M
What is the all time high annual EBIT for Lexeo Therapeutics?
Lexeo Therapeutics all-time high annual earnings before interest & taxes is -$4.59 M
What is Lexeo Therapeutics annual EBIT year-on-year change?
Over the past year, LXEO annual earnings before interest & taxes has changed by -$7.00 M (-11.83%)
What is Lexeo Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of LXEO is -$29.45 M
What is the all time high quarterly EBIT for Lexeo Therapeutics?
Lexeo Therapeutics all-time high quarterly earnings before interest & taxes is -$13.39 M
What is Lexeo Therapeutics quarterly EBIT year-on-year change?
Over the past year, LXEO quarterly earnings before interest & taxes has changed by -$9.40 M (-46.86%)
What is Lexeo Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of LXEO is -$86.44 M
What is the all time high TTM EBIT for Lexeo Therapeutics?
Lexeo Therapeutics all-time high TTM earnings before interest & taxes is -$15.13 M
What is Lexeo Therapeutics TTM EBIT year-on-year change?
Over the past year, LXEO TTM earnings before interest & taxes has changed by -$19.86 M (-29.84%)